Annual ARVO Report

14th Annual Report from ARVO

Topics covered at this year’s meeting range from corneal transplant outcomes to the eagerly-awaited results of AREDS2.
05/15/2013

ARVO: Retina

It’s an exciting time in the retina field. Researchers at ARVO 2013 reported on newly identified genetic factors in AMD and novel treatments for the disease, as well as FDA approval of a retinal prosthesis for RP and a new anti-VEGF agent for wet
05/15/2013

ARVO: Glaucoma

Researchers presented fresh data on new structural metrics, visual fields, blood flow and the latest glaucoma drug.
05/15/2013

ARVO: Cornea

From improved transplant procedures to scleral and bandage lenses, this year’s research focused on optimized corneal health.
05/15/2013

Upcoming Events

September 21, 2021

Understanding Diabetic Retinopathy and Diabetic Macular Edema
Location: Virtual Event
Speakers: Jeffry Gerson, OD, FAAO and David RP. Almeida, MD, MBA, PhD
8:00–9:00pm EST

Sponsored by Regeneron

Register here

September 30, 2021

Early Identification and Timely Referral
Location: Virtual Event
Speakers: Mohammad Rafieetary, OD, FAAO, and Jonathan Jonisch, MD
8:00–9:00pm EST

Sponsored by Regeneron

Register here

October 14, 2021

Treatment Option for Diabetic Retinopathy and Diabetic Macular Edema
Location: Virtual Event
Speakers: Mark T. Dunbar, OD, FAAO and Lloyd Clark, MD
8:00–9:00pm EST

Sponsored by Regeneron

Register here